Pfizer and its German partner BioNotech will supply 100 million more doses of their coronavirus vaccines to the US by this summer, after negotiations over how much they can deliver to companies given their commitments to other countries.
The $ 1.95 billion agreement doubles the overall US order of 200 million doses of the vaccine. Pfizer and Bayonet said they could supply 70 million doses by June 30, 2021, with the remaining 30 million doses delivered by the end of July.
A week after the extended agreement Health and Human Services Secretary Alex Azar told reporters that Pfizer was dealing with “manufacturing challenges”, the company denied the allegations. A spokesman said, “Pfizer has not had any production issues with its COVID-19 vaccine, nor has any shipment containing the vaccine been on hold or has been delayed.”